<svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 82 60" width="100%" height="100%" preserveAspectRatio="xMinYMin"> <path d="M75.537 1.333h-.985V.667h2.686v.666h-.985v2.711h-.76v-2.71h.044ZM77.641.71h1.12l.761 2.179.806-2.178h1.12v3.378h-.762V1.51l-.895 2.578h-.582l-.851-2.578v2.578h-.761V.71h.044ZM60.089 24.4c0 5.689-4.433 10.31-10.433 10.31-5.731 0-10.254-4.532-10.254-10.266 0-5.955 4.836-10.31 10.21-10.31 5.775-.045 10.477 4.444 10.477 10.266Zm-15.672 0c0 3.333 2.105 5.689 5.329 5.689 3.044 0 5.417-2.223 5.417-5.645 0-3.333-2.194-5.689-5.417-5.689-3.135 0-5.329 2.4-5.329 5.645Zm-28.119 7.733c-1.746 1.69-3.582 2.578-6.09 2.578-5.014 0-9.402-4.267-9.402-10.267 0-6.133 4.164-10.31 9.268-10.31 2.373 0 4.433.888 6.224 2.666v-2.133h4.926v19.555h-4.926v-2.089ZM5.776 24.4c0 3.333 2.239 5.822 5.328 5.822 3.045 0 5.418-2.267 5.418-5.867 0-3.422-2.283-5.733-5.418-5.733-3.268-.044-5.328 2.534-5.328 5.778ZM23.91 7.066h4.925v27.111H23.91V7.068Zm8.91 0h4.926v27.111H32.82V7.068Zm7.478 31.022h2.865l6.986 15.467 6.895-15.467h2.866l-9.537 21.245h-.493l-9.582-21.245Zm23.328 0h2.687v21.245h-2.687V38.088Zm7.254.001h2.731v3.11c.806-1.244 1.702-2.133 2.597-2.755a4.813 4.813 0 0 1 2.821-.889c.761 0 1.523.222 2.373.711l-1.388 2.311c-.582-.266-1.03-.355-1.433-.355-.895 0-1.746.355-2.597 1.111-.85.756-1.477 1.911-1.88 3.467-.314 1.2-.493 3.644-.493 7.333v7.2H70.88V38.089Z"/> <path d="M65.865 11.333c.493-.755.762-1.6.762-2.533 0-2.622-2.15-4.8-4.836-4.8-1.478 0-2.731.667-3.627 1.689a15.342 15.342 0 0 0-4.567-.711c-8.239 0-14.955 6.666-14.955 14.844 0 8.178 6.716 14.845 14.955 14.845S68.552 28 68.552 19.822c0-3.2-.985-6.089-2.687-8.489ZM53.597 32.667c-7.164 0-13.03-5.778-13.03-12.934 0-7.155 5.82-12.933 13.03-12.933 1.254 0 2.462.178 3.627.533A4.675 4.675 0 0 0 57 8.711c0 2.622 2.15 4.8 4.836 4.8.985 0 1.925-.311 2.686-.844a12.709 12.709 0 0 1 2.105 7.022c0 7.2-5.821 12.978-13.03 12.978Z"/> <path d="M56.731 4.178a6.786 6.786 0 0 1 5.06-2.223c3.806 0 6.895 3.067 6.895 6.845 0 1.022-.224 2-.627 2.844.269.445.493.89.672 1.378.761-1.244 1.209-2.667 1.209-4.222 0-4.445-3.672-8.09-8.15-8.09-2.596 0-4.925 1.245-6.402 3.112a14.8 14.8 0 0 1 1.343.356Z"/> </svg>
Communicating complex science for a wide variety of audiences
Biotech
Overview
AlloVir develops T cell (VST) therapies designed to prevent and treat life-threatening viral diseases. They are a global leader in this field. Their approach aims to restore viral immunity for patients fighting life-threatening infections through allogeneic, off-the-shelf, virus-specific T cell (VST) therapies.
solutions
Project outcomes
Site visitor increase
Increased sales
Challenges
The pace of progress within biotech is immense. Teams of researchers exploring potential therapies can coalesce around a new breakthrough, moving from the research team to fully operational potential therapeutic companies in months. These teams are often ill-equipped for operating successfully in a digital context. Therefore, talent marketing, digital marketing, brand strategy, and digital application development are must-haves that can slow the pace of growth within these high-potential businesses.
AlloVir needed to effectively translate advanced biotech concepts, therapeutic accomplishments, and research milestones into a cohesive and engaging story to support their internal growth goals, brand awareness, and market presence. Like many biotech companies, they didn’t have the early-stage resources to implement their desired effective digital marketing and brand strategies.
Solutions
Our work began with a digital maturity assessment to define the brand, digital, content, and organizational needs of AlloVir. We conducted a series of design sprints to rapidly excavate existing content and brand assets, and involved the entire leadership and scientific teams in hands-on concept development and future-state visioning exercises.
Building on years of experience in biotech and life sciences, the Agency 39A team quickly developed a content strategy that informed new mission, vision, values, and value proposition content, as well as a digital strategy that defined content, brand identity, user experience, and digital marketing tactics.
Results
Agency 39A’s work helped translate AlloVir’s innovation and expertise into a digital communications platform that increases investor awareness, builds investor confidence, and attracts world-class scientific talent.
Our reimagined content strategy across ADA-compliant digital platforms included more effective keyword-rich content and more robust scientific content for healthcare professionals. An increase in brand awareness was measured through improved digital analytics performance across all digital platforms, including web and social media.
By leveraging user insights, research, and business strategy UX design, we’ve evolved the digital brand to help AlloVir achieve its communication and awareness goals. We continue to serve AlloVir as a strategic design and technology partner.
